![Biomedicines | Free Full-Text | Systemic Corticosteroids and the Risk of Venous Thromboembolism in Patients with Severe COPD: A Nationwide Study of 30,473 Outpatients | HTML Biomedicines | Free Full-Text | Systemic Corticosteroids and the Risk of Venous Thromboembolism in Patients with Severe COPD: A Nationwide Study of 30,473 Outpatients | HTML](https://www.mdpi.com/biomedicines/biomedicines-09-00874/article_deploy/html/images/biomedicines-09-00874-g003.png)
Biomedicines | Free Full-Text | Systemic Corticosteroids and the Risk of Venous Thromboembolism in Patients with Severe COPD: A Nationwide Study of 30,473 Outpatients | HTML
![Predictive validity of short-form health survey [36 items] scales for chronic obstructive pulmonary disease exacerbation - Heart & Lung: The Journal of Cardiopulmonary and Acute Care Predictive validity of short-form health survey [36 items] scales for chronic obstructive pulmonary disease exacerbation - Heart & Lung: The Journal of Cardiopulmonary and Acute Care](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/93bca3e7-24a8-4884-bf21-ac2dd3307a55/gr1.jpg)
Predictive validity of short-form health survey [36 items] scales for chronic obstructive pulmonary disease exacerbation - Heart & Lung: The Journal of Cardiopulmonary and Acute Care
![SOLVED:7.Which kind disease develops quickly and runs its course quickly? Viral b) Congenital Chronic Acute 8.A reservoir I5 condition in which organisms remain in Ihe body for short time. source 0l micrabes SOLVED:7.Which kind disease develops quickly and runs its course quickly? Viral b) Congenital Chronic Acute 8.A reservoir I5 condition in which organisms remain in Ihe body for short time. source 0l micrabes](https://cdn.numerade.com/ask_images/b602cf55e150444881db141905fe83cb.jpg)
SOLVED:7.Which kind disease develops quickly and runs its course quickly? Viral b) Congenital Chronic Acute 8.A reservoir I5 condition in which organisms remain in Ihe body for short time. source 0l micrabes
![Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease - ScienceDirect Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213177919304019-fx1.jpg)
Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease - ScienceDirect
![Dr. Rachel Shelton on Twitter: "Applications are open for Institute for Implementation Science Scholars (IS-2)- a mentored training program for faculty interested in applying #impsci to address chronic disease inequities- this is Dr. Rachel Shelton on Twitter: "Applications are open for Institute for Implementation Science Scholars (IS-2)- a mentored training program for faculty interested in applying #impsci to address chronic disease inequities- this is](https://pbs.twimg.com/media/FF7yHUAWYAACSje.png)
Dr. Rachel Shelton on Twitter: "Applications are open for Institute for Implementation Science Scholars (IS-2)- a mentored training program for faculty interested in applying #impsci to address chronic disease inequities- this is
PwME 4 BioMEdical research on Twitter: "1. #ME is a chronic disease 2. Many are moderately ill, and that is serious 3. Large fluctuations or deteriorations are the typical courses of illness #
![Resolution of chronic inflammatory disease: universal and tissue-specific concepts | Nature Communications Resolution of chronic inflammatory disease: universal and tissue-specific concepts | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-05800-6/MediaObjects/41467_2018_5800_Fig1_HTML.png)
Resolution of chronic inflammatory disease: universal and tissue-specific concepts | Nature Communications
![PDF] Short-course fluoroquinolone therapy in exacerbations of chronic bronchitis and COPD. | Semantic Scholar PDF] Short-course fluoroquinolone therapy in exacerbations of chronic bronchitis and COPD. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ae08ce4f86509ef1b49a00a11d0f60e70babb6fb/6-Table2-1.png)